RecruitingNot Applicable

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

Brazil, Chile, Costa Rica35,000 participantsStarted 2018-02-17

Plain-language summary

To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Being 18 years or older
. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
. Providing written informed consent to participate in the registry

Exclusion criteria

. Having a life-threatening co-morbidity with life expectancy below 1 year
. Participating in an interventional trial requiring informed consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1This study seems to be a registry that collects detailed information about my condition — things like blood pressure readings, kidney function tests, and medications — rather than testing a new treatment, so would joining this registry change anything about how I'm currently being treated, or would I simply be sharing my existing health data?
2Since this registry is tracking real-world patterns across conditions like type 2 diabetes, chronic kidney disease, heart failure, and hypertension, and I have more than one of these, is there any benefit to me personally from participating, or is this primarily about building evidence to help future patients?
3The registry collects a lot of sensitive information including my physical measurements, lab results, family history, and healthcare visits — how would my data be protected, and would it be shared with researchers or companies outside my care team?
4Given how detailed the data collection is — covering everything from how often I get HbA1c tests to whether I've had cardiac surgery or dialysis — how much of my time would participation actually require, and would I need to come in for extra visits or tests beyond what my regular care already involves?
5Before considering this registry, would my doctor recommend focusing first on optimizing my current treatment plan for my specific conditions, since this study isn't evaluating a new therapy but rather observing how patients like me are managed in the real world?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

1. Age of particpants

Timeframe: At Baseline

2. Percentage of Participants by Sex

Timeframe: At baseline

3. Percentage of Participants by Ethnicity

Timeframe: At Baseline

4. Percentage of Participants by Education Level

Timeframe: At Baseline

5. Percentage of Participants by Marital Status

Timeframe: At Baseline

6. Percentage of Participants with Family History of Cardiovascular and Renal-Metabolic Disease

Timeframe: At Baseline

7.Percentage of Participants by Physical Activity Level

Timeframe: At Baseline

8. Percentage of Participants by Smoking Status

Trial details

NCT IDNCT03549754

SponsorAstraZeneca

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2030-12-31

Contact for this trial

AstraZeneca Clinical Study Information Center

1-877-240-9479 information.center@astrazeneca.com

View on ClinicalTrials.gov More Type 2 Diabetes trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Being 18 years or older
. Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
. Providing written informed consent to participate in the registry

Exclusion criteria

. Having a life-threatening co-morbidity with life expectancy below 1 year
. Participating in an interventional trial requiring informed consent

What they're measuring

1. Age of particpants

Timeframe: At Baseline

2. Percentage of Participants by Sex

Timeframe: At baseline

3. Percentage of Participants by Ethnicity

Timeframe: At Baseline

4. Percentage of Participants by Education Level

Timeframe: At Baseline

5. Percentage of Participants by Marital Status

Timeframe: At Baseline

6. Percentage of Participants with Family History of Cardiovascular and Renal-Metabolic Disease

Timeframe: At Baseline

7.Percentage of Participants by Physical Activity Level

Timeframe: At Baseline

8. Percentage of Participants by Smoking Status